Drug intelligence / Profile preview

fluoxetine + lovastatin

Development stage
Unknown
Lead developer
Eli Lilly
Modality
Small Molecules
Administration
Oral
01

Overview

Fluoxetine + lovastatin is a combination of two small molecule drugs, fluoxetine (a selective serotonin reuptake inhibitor antidepressant) and lovastatin (an HMG-CoA reductase inhibitor statin). This combination has been studied for its potential to enhance the treatment of major depressive disorder (MDD), with evidence suggesting that adding lovastatin to fluoxetine may improve depressive symptoms more than fluoxetine alone. Fluoxetine works by inhibiting the reuptake of serotonin in the brain, increasing its availability and thereby improving mood. Lovastatin lowers cholesterol by inhibiting HMG-CoA reductase but may also have anti-inflammatory and neuroprotective effects that could contribute to improved depression outcomes when used adjunctively with SSRIs[1][3][7].

02

Targets

CYP2D6 (Cytochrome P450 2D6)SERT (Sodium-dependent serotonin transporter)HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)

Beyond the preview

Go deeper on fluoxetine + lovastatin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fluoxetine + lovastatin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call